MDS Pharma Services Divests Fermentation Technologies Business

December 19, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, announced the sale of its Fermentation Technologies business to Panlabs Biologics of Taiwan, effective today. The move is one of a number of actions taken over the past year to focus the business on its core strengths.

MDS Pharma Services' Beijing Lab Earns Diabetes Distinction

October 28, 2005 - MDS Pharma Services, a leading provider of drug discovery and development solutions, today announced that its central laboratory in Beijing, China, has gained Level 1 certification for HbA1c testing from the National Glycohemoglobin Standardization Program (NGSP). Managed by the University of Missouri, the NGSP is dedicated to improving diabetes care by standardizing glycohemoglobin/hemoglobin A1c testing, a critical tool for monitoring the effectiveness of therapies to treat diabetics. The Beijing facility is one of 10 MDS Pharma Services-owned or affiliated laboratories to achieve this status, which reflects the highest levels of technical precision and accuracy in assessing HbA1c test results.

MDS Pharma Services Expands Early Clinical Research Capacity in Lincoln, Nebraska

August 11, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, is proceeding with a 30 per cent increase in capacity at its Early Clinical Research (ECR) site in Lincoln, NE to satisfy growing client demand. The expansion at the Lincoln facility will strengthen MDS Pharma Services' position as one of the largest providers of Phase I research services, with more than 1,000 beds at seven facilities in North America and Europe.

MDS Pharma Services names Vice-President of Quality

August 10, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, today announced the hiring of Robert Castellucci to fill the newly created position of Vice-President of Quality. He will report directly to MDS Pharma Services President and CEO Gilbert Godin and will be located in the business' executive office in King of Prussia, Pa.

MDS Pharma Services to Manage Clinical Trials of Anti-Malarial in Asia and Africa

August 10, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has been selected to manage Phase III clinical trials of the anti-malarial drug Eurartekin™ by Sigma-Tau, a research-based Italian pharmaceutical company. The trials will be conducted according to Good Clinical Practice (GCP) standards and will involve 2,550 malaria patients in China, Laos, Thailand, Burkina Faso, Kenya, Mozambique, Uganda and Zambia. Patient enrolment began in June 2005 and the trials are expected to be completed by the end of 2006, followed by application for registration of Eurartekin™ in Europe in mid-2007 and later in malaria-endemic countries in Africa and Asia.

MDS Pharma Services Sponsors The Biomarker Alliance™

June 16, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has spearheaded the formation of The Biomarker Alliance™ (www.biomarkeralliance.com) serving the pharmaceutical and biotechnology industries. The Biomarker Alliance, which will design and execute a wide range of biomarker discovery and development programs, is made up of the world-class biomarker service providers Caprion Pharmaceuticals, Gentris Corporation, Massachusetts General Hospital Department of Radiology and MDS Pharma Services.

MDS Pharma Services Expands Clinical Research Capabilities in Asia-Pacific

June 7, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has announced the opening of new facilities in Sydney, Australia, and Petaling Jaya, Malaysia. Under the leadership of Dr. Greg Voinov, MDS Pharma Services general manager of Asia-Pacific, these facilities offer global clinical development solutions and add to the company's growing presence in the region.

MDS Pharma Services to Host Pharmaceutics-Focused Seminar in San Diego

May 26, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, will host a free pharmaceutics-focused Scientific Leadership Series seminar on "Increasing the Value of Your Small Molecule through Expedited Strategies Leading to First-in-Man Oral Dosing," in La Jolla, California, on June 16, 2005. Industry experts will address early phase development challenges associated with achieving speed to first-in-man studies.

MDS Pharma Services Takes Action to Enhance Performance and Profitability

May 12, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, announced today two major capital programs in addition to changes to the structure of its Canadian bioanalytical laboratories.

MDS Pharma Services Offers Microdose-enabling Manufacturing Capabilities In Support of Exploratory IND Studies

May 10, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has announced that their Tampa, Fla., pharmaceutics division has expanded manufacturing capabilities to include precision microdosing automation, enabling clients to conduct Phase 0 studies and move efficiently toward clinical proof-of-concept. These capabilities are in close alignment with FDA efforts to streamline drug development by endorsing the use of exploratory IND studies which, as defined by the FDA, involve very limited human exposure and no therapeutic intent (e.g. screening studies, microdose studies).

MDS Pharma Services Granted cGMP License for Belfast Facility

May 9, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has issued accreditation to the pharmacy at its clinical research facility in Belfast, Northern Ireland. The pharmacy meets all Good Manufacturing Practice (cGMP) standards established by the European Union Clinical Trials Directive for manufacturing and dispensing investigational medicinal products for clinical studies at all MDS Pharma Services European early clinical research sites, including Belfast, Northern Ireland and Munich and Hamburg, Germany.

MDS Pharma Services Hosts Grand Opening of Expanded Central Lab Facility in Singapore

April 12, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, hosted a grand opening event for its newly expanded central lab facility in Singapore on Monday, April 11. The expansion grand opening included a ribbon-cutting ceremony, a lion dance to bring good fortune and facility tours. A gala dinner followed at the Raffles City Convention Centre.

MDS Pharma Services Purchases Xcelodose™ 600

April 08, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has announced the purchase of an XcelodoseTM 600, a precision powder micro-dosing system/automated encapsulator with a fill range of 100 micrograms to greater than 100 milligrams. Housed at the company's Tampa, Fla., facility, this machine is the first of its kind to be utilized by a contract research organization in North America.

MDS Pharma Services Announces New Vice President, Clinical Pharmacology

March 17, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has appointed Vijay Vashi, Ph.D., vice president, Clinical Pharmacology. Based out of the business's Neptune, NJ, facility, he will provide clinical, scientific and operational leadership, including clinical pharmacology expertise, to client studies and interact with MDS Pharma Services operations and scientific personnel in support of Phase I clinical studies.

MDS Pharma Services to Host Grand Opening of Expanded Singapore Facility

March 3, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, will host a grand opening event for its newly expanded Singapore facility. This expansion houses MDS Pharma Services' growing presence in Singapore, which currently includes central lab and ECG study coordination services, logistics and global clinical development services.

Appointments Strengthen MDS Pharma Services Bioanalytical Operations in Europe

February 16, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions and a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), has appointed five new senior staff members to its bioanalytical operations in Sittingbourne, United Kingdom, and Zurich, Switzerland.

MDS Pharma Services’ Clinical Research Named Top Business in Romania for a Second Year

February 11, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has announced that its Romanian clinical research group was named the top R&D and high-tech business of 2004 by the Chamber of Commerce and Industry of Romania.

MDS Pharma Services to Host Symposium on Effective Solutions for Pharmaceutical Development Challenges

February 7, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions and an integral part of MDS Inc. (TSX: MDS; NYSE: MDZ), will host a pharmaceutics-focused Scientific Leadership Series symposium on February 23-24 in Tampa, Florida. Leading researchers from industry and academia will address the scientific and regulatory challenges associated with speed to first-in-man studies for new chemical entities and life-cycle management for existing branded compounds.

MDS Pharma Services and FDA Dialogue

February 7, 2005 - As part of its ongoing dialogue with the U.S. Food and Drug Administration (FDA), MDS Pharma Services met with the Agency on February 2nd, 2005 to present and discuss a plan to review bioequivalence studies conducted at the company's Montreal Bioanalytical facility.

MDS Pharma Services Hires Dr. Lee Schacter as Staff Oncologist

January 24, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has hired its Oncology Medical Advisory Board member Dr. Lee Philip Schacter, Ph.D., M.D., as its full-time staff Oncologist, based at the organization's executive offices in King of Prussia, PA.

MDS Pharma Services Announces New Vice President of Global Marketing

January 18, 2005 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has appointed Robert D. Lefebvre vice president of Global Marketing. Mr. Lefebvre is responsible for all aspects of marketing strategy and implementation for the organization and is based at the King of Prussia, PA, office.